Home > Blog Tag

Blog Posts by Tag: COVID-19

XIFIN LIS Keeps Laboratories Nimble: Responding Quickly to Fluctuations in COVID-19 Testing Demand and Turnaround Times

Early in the COVID-19 pandemic, laboratories were focused on the capabilities needed to get them ramped up quickly to handle COVID-19 testing. As 2020 wore on, labs were challenged to keep up with significant fluctuations in COVID testing volume, as well as ongoing shortages in test supplies.In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced that starting January 1...

Read


Q&A Explores COVID's Impact on Lab Industry Testing Volumes and Dynamics

In a recent teleconference among XIFIN and UBS executives, XIFIN’s Chairman and CEO Lâle White and Chief Operating Officer Kyle Fetter discussed COVID-19's impact on lab industry testing volumes and dynamics.The one-hour conference revealed: Hospital volumes have come back stronger than any other sector Molecular volumes are doing well Genetic testing is continuing to increase with more...

Read


XIFIN Innovation Drives Growth in Four Critical Business Areas During COVID-19

Despite COVID-19's industry-altering effects on diagnostic labs and healthcare in general, XIFIN innovation in 2020 drove growth in four critical business areas: digital and genomic health, remote patient monitoring and medical device, healthcare informatics oncology, and traditional laboratory markets.XIFIN also generated notable client results and provided unique insights into lab testing...

Read


COVID-19's Impact on Lab Industry Testing Volumes and Dynamics — January 2021 Update

During a recent update on COVID-19's impact on lab testing volumes and dynamics, XIFIN Executive Chairman & CEO Lâle White said XIFIN is continuing to see a week over week increase in the overall volume of PCR testing following the winter holidays. Testing volume for December overall saw a slight downshift, mostly due to holiday activity. "The base volume is really back for most...

Read


Top 5 Blog Posts of 2020

Through one of the most challenging years for the healthcare industry, XIFIN contributed thought-provoking articles to help traverse these difficult times. Here are 2020's most popular blog posts.1. How Upcoming Changes to United Health's Laboratory Test Registry May Impact Your LabWhen the COVID-19 pandemic was declared, United Healthcare (UHC) delayed implementing the Laboratory Test Registry...

Read


Labs’ Critical Role in the Patient Care Journey and the Many Challenges to Keep up with COVID Testing Volumes

Enjoy the following content from our partner, FrontRunnerHC. For many years, labs — both independent labs and within hospitals — have worked behind the scenes, quietly playing a critical role in the patient care journey. In fact, the lab is often one of the first crucial steps in that journey, providing information to help keep us, or potentially get us, healthy.In many ways, the COVID-19...

Read


Digital Pathology Trends and the Impact of COVID-19 on Speed of Adoption

Digital pathology was introduced decades ago as a way for sharing digital images across laboratories, enabling pathologists to work together on cases and enhance the accuracy of diagnostic techniques. Before the COVID-19 pandemic, U.S. adoption of digital pathology lagged behind most other developed countries.The COVID-19 pandemic accelerated the adoption of digital pathology in this country for...

Read


The CDC Offers a Multi-Virus Testing Option with the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

With flu season typically starting in October and peaking between December and February, the Centers for Disease Control and Prevention (CDC) have developed two tests that identify the COVID-19 virus (SARS-CoV-2). The latest of these two tests, called the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, tests for influenza A and B viruses as well as SARS-CoV-2.Along with the new test, the...

Read